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Abstract 
 
IgE is an ancient and conserved immunoglobulin isotype with potent immune function. 
Nevertheless, the regulation of IgE responses remains enigmatic and evidence for a role of IgE 
in host defense is limited. Herein we describe that topical exposure to a common environmental 
DNA-damaging xenobiotic initiated stress-surveillance by TCR+ intraepithelial lymphocytes 
resulting in class-switching to IgE in B cells and accumulation of autoreactive IgE. High-
throughput antibody sequencing revealed that T cells shaped the IgE repertoire by 
supporting specific VDJ rearrangements with unique CDRH3 characteristics. This endogenous 
IgE response, via the FcRI, protected against epithelial carcinogenesis and FceR1a expression 
in human squamous cell carcinoma correlated with good disease prognosis. This data indicate 
a joint role for T and B cell immune-surveillance in epithelial tissues and suggests that IgE is 
part of the host defense against epithelial damage and tumor development. 
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IgE is an ancient and highly conserved immunoglobulin isotype found in all mammals1. It is 
thought that IgE has evolved to provide protection against infection by macroparasites, such as 
helminths. However, although IgE is elevated in both mice and humans with helminth 
infections, IgE is not critical for protective immunity against helminths and much of the IgE 
raised is not parasite-specific2. An alternative hypothesis suggests that IgE is important for 
immune responses against environmental toxins such as venoms3, and indeed, recent data 
indicates that IgE can protect against bee venom and limit snake venom toxicity4, 5, 6. 
Furthermore, aberrant IgE responses causing allergies are frequently directed at environmental 
irritants and non-replicating agents. A role for IgE in defending against immediate danger 
would be consistent with the very rapid mobilization of its effector functions. Therefore a 
broader paradigm proposes that IgE represents an arm of early immune host-defense against 
xenobiotics or large parasites threatening tissue integrity7. However, what drives these IgE 
responses in vivo, what they recognize and whether they play a wider role in immune defense 
remain unknown. 
 
IgE responses occur most frequently in epithelial tissues such as the skin, lung and gut, which 
contain resident IgE-binding cells. These barrier surfaces are continuously exposed to 
challenges from environmental xenobiotics and a prominent feature of their response to 
external insults is induction of type 2 immunity8 and IgE9, 10. In the murine skin epithelia, a 
resident TCR+ population of intraepithelial lymphocytes (IEL) controls tissue homeostasis 
via induction of IL-1311, a type 2 cytokine, and also promotes IgE upon challenge with protein 
allergens on stressed tissue12. These IELs can directly sense epithelial cell dysregulation via 
stress-sensing receptors, such as NKG2D, and this pathway plays a key role in promoting the 
IgE response12, 13. The capacity of IELs to detect epithelial cell stress and initiate a restorative 
response has been termed lymphoid stress-surveillance and plays an important role in early 
detection of stressed and pre-malignant cells13. Indeed, tissue-specific IELs regulate epithelial 
tissue integrity and are key to host-protection against carcinogenesis11, 13.  
 
Many toxins and xenobiotics are also carcinogens. Hence, in defending against environmental 
xenobiotics, IgE may simultaneously confer protection against transformation and cancer in 
exposed tissues. Here we report the development of a potent and dominant IgE response 
following topical exposure to the common environmental xenobiotic and carcinogen, 7,12-
dimethylbenz[a]anthracene (DMBA). This endogenous IgE response was autoreactive and was 
required for protection against cutaneous carcinogenesis. Further, we show that tissue-resident 
TCR+ IELs had a unique role in initiating and regulating IgE production, driving an early, 
innate-like response, which directed a subsequent adaptive response supported by IL-4-
producing CD4+ T cells. Deep-sequencing of IgE and IgG1 from germinal center (GC) B 
cells and plasma cells (PCs) indicated that TCR+ IELs shaped a distinct IgE repertoire that 
was dependent on the presence of DNA-damage in epithelial cells. Thus, lymphoid stress-
surveillance promoted a unique IgE response, which was part of an early host defense 
mechanism providing protection against cancer.      
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Results 
 
Carcinogen-induced epithelial cell damage triggers IgE responses 
DNA-damaging xenobiotics such as DMBA are commonly found in the environment and have 
been implicated in carcinogenesis14, 15. We found that a single topical application of DMBA to 
the back skin of wild-type mice induced an IgE response in serum within 4 days (Fig. 1a). 
DMBA exposure was associated with upregulation of the NKG2D-ligand Rae-1 on skin 
epithelial cells (Supplementary Fig. 1a), indicating epithelial cell stress. The number of 
epithelial cells containing double-stranded (ds) DNA-breaks, assessed by staining for the 
phosphorylated histone H2A variant H2AX (γH2AX), peaked between 3-7 days after DMBA 
exposure (Supplementary Fig. 1b,c). Epidermal Langerhans cells (LCs) must metabolize 
DMBA to the more mutagenic compound DMBA-trans-3,4-dihydrodio to cause substantial 
DNA-damage. Langerin-DTA mice, which do not have LCs, showed less epithelial cell DNA-
damage following a single dose of DMBA16 (Supplementary Fig. 1d) and failed to show 
increased serum IgE compared to non-transgenic littermate controls (NLC) (Fig. 1b). 
However, Langerin-DTA mice generated IgE to other topical challenges12 and, if exposed to 
DMBA repeatedly, they developed both DNA-damage and IgE responses (Supplementary 
Fig. 1d,e). Other DNA-damaging skin challenges such as UV-irradiation also induced IgE 
(Supplementary Fig 1f,g). Once weekly exposure to DMBA led to the development of 
papillomas and squamous cell carcinomas (SCCs) after 8-15 weeks. This was associated with 
high amounts of serum IgE, which rose progressively as epithelial DNA-damage accumulated 
(Fig. 1c). When DMBA was given daily for 5 days only, mice developed skin tumors and 
serum IgE showed a progressive rise during 12 weeks (Supplementary Fig. 1h). The systemic 
IgE responses were paralleled by infiltration and accumulation of IgE in acutely damaged skin 
(Fig. 1d) and in skin tumors (Fig. 1d,e). The tissue IgE was mainly carried by FcRI-expressing 
basophils (Fig. 1d). More mature IgE transcripts were expressed in the tumor tissue than the 
adjacent skin, indicating some local IgE production, whereas IgG1 and IgM transcripts were 
lower in tumors than adjacent skin (Fig. 1f). This data indicate that the epithelial cell damage 
triggered by DMBA exposure potently promoted IgE production which accumulated in the 
resulting skin tumors.   
 
Topical carcinogen exposure induces local B cell class-switching 
To investigate the origin of the DMBA-induced IgE response, we examined B cells in the skin-
draining LNs during acute DMBA exposure (pre-malignancy). Two applications of DMBA, 3 
days apart, on the ear skin induced enlarged skin-draining LNs with formation of GCs and 
class-switching of GC B cells (Fig. 2a) as well as increased numbers of CD138+ PCs, which 
had class-switched primarily to IgE and IgG1, with little or no induction of IgG2a (Fig. 2b). 
There was no induction of GCs or class-switched PCs in the spleen (data not shown), 
suggesting the response was localized to the skin-draining LNs. Weekly exposures to DMBA 
on back skin for 5 weeks also induced GCs and IgE+ and IgG1+ PCs. However, under these 
conditions, the GC structures and the IgG1+ PCs diminished from week 3, resulting in a 
dominant IgE response (Fig. 2c). By week 5 post-exposure, nearly 80% of all CD138+ PCs in 
the LNs had switched to IgE (Fig. 2c). Thus, skin exposure to DMBA promotes a local type 2 
B cell response with dominant and prevailing IgE production.  
 
Carcinogen-induced IgE protects against carcinogenesis 
To explore whether the IgE response induced by DMBA was important for host defense, we 
assessed skin tumor formation in Igh7-/- mice, which lack IgE. Following once weekly DMBA 
exposure Igh7-/- mice developed tumors sooner and more rapidly, as well as  significantly more 
and larger tumors than their wild-type counterparts (Fig. 3a). The IgG1 response in the DMBA-
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treated Igh7-/- mice was identical to wild-type mice (Supplementary Fig. 2a). In addition, the 
number of IgE-effector cells in the tissue was similar to wild-type (Supplementary Figure 
3a). FceR1a-/ mice, which lack the high affinity receptor for IgE, also had enhanced 
susceptibility to DMBA carcinogenesis compared to wild-type (Fig 3b), despite having similar 
IgE and IgG1 amounts in serum (Supplementary Fig 2b), suggesting the protective effect of 
IgE was mediated by signaling through FcRI . CD45locKit-FcRI+ basophils represented the 
main IgE+ cell population in the tumors (Fig. 1d). Cpa3Cre/+ mice, which have Cre-recombinase 
inserted in the Cpa3 locus, and lack skin mast cells, showed similar susceptibility to tumor 
development as Cpa3+/+ littermates following DMBA carcinogenesis, suggesting that, most 
likely, FcRI+ basophils mediated the protection against carcinogenesis (Supplementary Fig. 
3b). Splenic CD45locKit-CD41+FcRI+ basophils from Igh7-/- mice produced IL-4 and IL-6 and 
degranulated equivalent to basophils from wild-type spleens upon PMA/ionomycin 
stimulation, however the skin tumour cytokine microenvironment was significantly altered in 
Igh7-/- mice compared to wild-type (Supplementary Fig. 3c-e).  
To investigate whether similar IgE responses occur in humans, we analyzed  newly incised 
skin SSC samples from 12 patients. FcRI+ cells were found in all tumor and peri-lesional skin 
samples, varying in frequency from around 1% to over 40% of the tumor infiltrating CD45+ 
leukocytes (Fig. 3c). The FcRI+ cells were mainly found in the peritumoral infiltrate at the 
interface between the stroma and the neoplastic keratinocytes with some entering the tumor 
and/or hair follicle (averaging 11.72.9 cells per mm2) (Supplementary Fig. 4). FcRI+ cells 
accumulated more in the skin compared to matched blood samples, however, tumor tissue 
contained fewer FcRI+ cells than histopathologically healthy peri-lesional skin from the same 
patient (Fig. 3c). In an additional cohort of 56 SCC patients, gene-expression analysis revealed 
that expression of FceR1a mRNA was higher in unaffected skin areas than in developed 
tumors, with the lowest expression of FceR1a mRNA detected in high-risk and metastatic 
SCCs (Fig. 3d). A significant linear trend was observed between FceR1a mRNA expression 
and the risk for more advanced SSC (Fig. 3d). Together these data indicate that IgE, via FcRI, 
protected against DMBA-induced SCC and that fewer FcRI-expressing leukocytes in human 
SSC correlates with risk of more severe disease.  
 
Carcinogen-induced humoral immunity depends on T cell-derived IL-4 
Conventional and non-conventional modes of inducing class-switching to IgE have been 
described8. We first explored whether induction of tumor-protective IgE was dependent on 
T cells. Tcrb-/- mice, which lack  T cells, had no enlargement of skin-draining LNs, no 
GCs, and no IgG1+ or IgE+ PCs following twice topical DMBA to the ear skin compared to 
wild-type mice (Fig. 4a). The response was restored by transferring polyclonal CD4+ T cells, 
but not TCR-restricted transgenic OTII CD4+ T cells in Tcrb-/- mice (Supplementary Fig. 5a), 
indicating it was dependent on a normal TCR repertoire. Furthermore, injection of -CD40L 
blocking antibody partially inhibited LN enlargement and repressed GC formation and 
generation of IgE+ and IgG1+ PCs in wild-type mice (Supplementary Fig. 5b). Similar defects 
in class-switching to IgE+ and IgG1+ PCs were seen Il4-/- mice, which cannot produce IL-4, 
although Il4-/- mice showed an enlargement of LNs comparable to wild-type mice and had some 
GC B cells (Fig. 4a). Il4-/- mice had some class-switching to IgG2a, which was never observed 
in wild-type or in Tcrb-/- mice (data not shown). Wild-typeIl4-/- BM chimeras induced IgE+ 
and IgG1+ PCs comparably to wild-typewild-type chimeras following topical DMBA 
treatment, whereas Il4-/-wild-type chimeras induced significantly less IgE+ and IgG1+ PCs 
(Supplementary Fig. 5c), indicating IL-4 was derived from haemapoeitic cells, and not 
irradiation-resistant skin-resident cells. To test whether the requirement for  T cell for 
IgE/IgG1 class-switching reflected a need for IL-4, we reconstituted Tcrb-/- mice with wild-
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type or Il4-/- CD4+ T cells 24hr prior to DMBA exposure. Only the wild-type CD4+ T cells 
were able to rescue the GC response and IgG1/IgE production in the skin-draining LN of the 
reconstituted Tcrb-/- mice (Fig. 4b). Moreover, Il4-/- mice showed significantly earlier onset, 
higher incidence of tumors and larger tumors compared to wild-type controls following weekly 
DMBA treatment (Fig. 4c), indicating that IL-4 was required for tumor protection. Tumor-
bearing Il4-/- mice did not produce IgE and had diminished production of IgG1, but higher 
IgG2a, in serum compared to wild-type (Supplementary Fig. 2c). Thus,  T cell-derived IL-
4 is critical for IgE production and tumor protection following DMBA exposure.  
 
Induction of tumor-protective IgE requires  TCR+ IEL 
Skin TCR+ IELs are key for protective immunity against chemical carcinogenesis and are 
strong inducers of local type 2 immune responses11, 12, 13. We found that Tcrd-/- mice, which 
lack T cells, had less LN hypertrophy following topical DMBA exposure to the ear skin, but 
normal numbers of GC B cells compared to wild-type mice (Fig. 5a). Tcrd-/- mice developed 
comparable IgG1+ PCs, but had significantly impaired IgE PC responses compared to wild-
type mice (Fig. 5a). The reduction in IgE was already detected at day 4, a time-point when the 
numbers of IgE+ PCs and serum IgE were increased in wild-type mice, but remained 
undetectable in Tcrd-/- mice (Fig. 5a,b). GCs were not yet enlarged in wild-type mice at day 4 
(Fig. 5a), suggesting that the  T cell-dependent IgE response at this time may be of extra-
follicular origin. To explore this, we utilized CD19creBcl-6fl/fl mice, which have a B cell-
specific defect in the transcription factor Bcl-6. CD19creBcl-6fl/fl mice did not develop a GC 
response following topical DMBA application, despite LN enlargement, but the number of 
IgE+ and IgG1+ PCs in the LN were equivalent to in Bcl-6 heterozygous littermates and wild-
type mice (Supplementary Fig. 5d). We next asked whether the  T cells involved in the 
response were located in the skin itself or in a secondary lymphoid organ such as the draining-
LNs. Skin resident TCR+ IELs are radiation-resistant11 and in Tcrd-/-wild-type and wild-
typeTcrd-/- BM chimeras  T cells were detected only in the skin or LNs respectively (Fig. 
5c). When these chimeras were treated topically with DMBA, IgE was significantly reduced 
only in wild-typeTcrd-/- chimeras, in which TCR+ IELs were missing from the skin, but  
T cells were present in the LNs, compared to wild-type chimeric controls (Fig. 5d). The number 
of IgG1+ PCs was similar in Tcrd-/-wild-type, wild-typeTcrd-/- and control chimeras (Fig. 
5d). The V4+ and other ‘non-V5+’  T cells in the skin of Tcrd-/-wild-type, wild-
typeTcrd-/- chimeras were similar to wild-type chimeric controls (Fig. 5c). In addition, 
Vg5Vd1-/- mice, which lack only the canonical V5V1+ IELs, had fewer IgE+ PCs following 
topical DMBA treatment compared to wild-type mice (Fig. 5e), suggesting that V5+ IELs 
were most likely the IgE-promoting  T cell subset. These observations indicate that DMBA-
induced IgE depended on TCR+ IEL in the tissue.  
 
 T cells promote a distinct IgE repertoire in response to carcinogen 
To understand the nature of the humoral response produced during epithelial cell damage, and 
the role of  T cell immune-surveillance, we sorted B220+CD95+GL7+ GC B cells and 
FSChiCD95hiCD138+ PCs from the skin draining LNs of wild-type and Tcrd-/- mice 7 days after 
the last of two topical DMBA exposures. Analysis of the IgG1 and IgE heavy-chain repertoires 
using high-throughput sequencing revealed that IgE-producing clones had the largest clone 
expansion in wild-type mice (Supplementary Fig. 6a). As expected, the average clone sizes 
for IgG1 were greater amongst PCs than GC B cells (Fig. 6a). In contrast, IgE clones among 
PCs and GC B cells were equivalent and were larger than IgG1 clones (Fig. 6a). Furthermore, 
Tcrd-/- mice had defective IgE clone expansion in GC B cells compared to wild-type, while 
IgG1 clone expansion was similar (Fig. 6b). Alakazam tool17, an analysis framework for 
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adaptive immune-receptor repertoire sequencing, indicated that the IgE+ PC repertoire was 
significantly less diverse in Tcrd-/- compared with wild-type mice in all but the most common 
clones (Fig. 6c). In contrast, the IgG1+ PC repertoire diversity in Tcrd-/- mice was similar to 
wild-type (Fig. 6c).    
 
We also analyzed the physicochemical properties of the CDRH3 regions using principal 
component analysis (PCA) of Kidera factors18, which are a set of independent factors 
encapsulating information from 188 different biophysical characteristics of the 20 amino acids. 
We observed clear differences in the CDRH3 protein structure between GC B cells and PCs as 
well as between IgG1-switched and IgE-switched clones in wild-type mice (Fig. 6d), indicating 
that the majority of IgE+ PC clones were of extra-follicular origin and had switched directly 
from IgM to IgE. This was supported by clonal analysis, which indicated that <30% of IgE+ 
PC clones were shared with IgG1+ PC clones and only around 30% of IgE+ PC clones were 
shared with IgE+ GC clones (Supplementary Fig. 6b,c). Furthermore, Kidera PCA showed 
that the properties of IgE and IgG1 in Tcrd-/- mice were different from those of wild-type mice, 
suggesting that immune-surveillance by  T cells had a role in selecting the physiochemical 
properties of the CDRH3 regions (Fig. 6d). 
Selection events are also expected to shape the B cell repertoire in terms of V, D, J gene-usage. 
We found that only 5 major IgHV and 5 IgHD family genes were commonly used, but all 4 
IGHJ genes were used for both IgG1+ and IgE+ GC B cells and PCs (Supplementary Fig. 6d-
f). The third most frequent D gene in both IgE+ and IgG1+ GC B cells and PCs could not be 
annotated by IMGT, most likely due to an IGHD gene in the FVB genome that is absent from 
the IMGT genomic data, as the heavy chain repertoire is highly variable between inbred 
strains19. We annotated this new gene as Dx. 3D analysis of VDJ usage in IgE+ PCs indicated 
that V1D2 was the dominant selection (Fig. 6e), consistent with data showing that the IgHV1 
family is most frequently used in mouse Ig19, 20. J usage was approximately equal between the 
4 J family groups (Fig. 6e). The VDJ analysis also revealed that some VDJ combinations in 
wild-type mice, particularly the novel V3Dx segment, were significantly less selected in IgE+ 
PCs from Tcrd-/- mice (Fig. 6e-g).  
We next compared the physicochemical properties of CDRH3 in the wild-type V3Dx clones 
with those of V3D2 clones, which used the same V but different D gene, V1D2 clones, which 
were the most common selection and V14D2 clones, which did not require  T cell selection. 
Kidera factor PCA indicated that the V3Dx clones had unique CDRH3 physicochemical 
characteristics (Fig. 6h) and contained a lower frequency of aromatic and small amino acids, 
but a higher frequency of aliphatic and basic amino acids, as well as a higher isoelectric point 
than clones of the other VD combinations (Fig. 6i). These characteristics suggest that the 
antigen-binding site was hydrophobic, with slight positive charge in the loop at blood pH. In 
addition, the V3Dx-expressing clones had shorter CDRH3 regions than the V1D2 and V3D2 
clones (Fig. 6i), indicating antigen selection21, 22, and carried fewer mutations (Fig. 6j), 
indicating they were more germline in nature. In sum, this data indicates that in response to 
DMBA, TCR+ T cells shaped the IgE repertoire by supporting specific VDJ rearrangements, 
resulting in unique characteristics of the CDRH3 antigen-binding site that suggests 
polyreactive autologous binding. 
 
DMBA-induced IgE is autoantigenic and differs from TPA-induced IgE 
We next explored whether the IgE responses induced by topical DMBA were auto-reactive. 
We screened the binding of IgE, from serum of DMBA-treated wild-type mice, to human HEp2 
cells and observed several strong staining patterns (Fig. 7a and Supplementary Fig. 7a), 
indicating both autoreactivity and cross-species reactivity of IgE. The most common staining 
patterns of IgE on HEp2 cells were ‘nuclear dots’, which indicate anti-nuclear specificity and 
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‘cytoplasmic vesicles’ that resembled stress granules (Fig. 7a and Supplementary Fig. 7a). 
In addition, we detected IgE reactivity towards ds-DNA (Fig. 7b) and towards damaged 
epithelial cells, frequently around hair-follicles, in epidermal sheets from FceR1a-/- mice 
isolated 24hr after DMBA exposure (Supplementary Fig. 7f-g). We detected no autoreactivity 
against HEp2 cells with IgE from serum of DMBA-treated Tcrd-/- mice or IgE from serum of 
wild-type mice treated topically with 12-O-tetradecanoylphorbol-13-acetate (TPA) (Fig. 7a 
and Supplementary Fig. 7b,c), which did not provoke epithelial cell DNA-damage (Fig. 7c), 
but triggers general skin inflammation.  
We next sorted FSChiCD95hiCD138+ PCs from the skin draining LNs of wild-type mice 
exposed topically to DMBA or TPA and compared their IgE heavy-chain repertoires using 
high-throughput sequencing. Alakazam analysis indicated that TPA-induced IgE+ PCs 
exhibited significantly less diversity throughout the repertoire compared to DMBA-induced 
IgE+ PCs (Fig. 7d). Kidera factor PCA indicated more heterogeneity in the CDRH3 regions of 
TPA-induced IgE compared with DMBA-induced IgE, with little overlap between the two 
responses (Fig. 7e). In parallel, VDJ gene family-usage amongst TPA-induced IgE was 
dominated by V1 genes, with significantly less selection for V3 and V14 genes compared to 
DMBA-induced IgE (Fig. 7f,g). Notably, TPA also did not generate the V3Dx-expressing 
clones, which we had found to be promoted by  T cells in response to DMBA-induced DNA-
damage (Fig. 7g). Together these results indicate, that skin exposure to DMBA drove a unique, 
autoreactive IgE repertoire that was distinct from that induced in response to TPA, which 
induced local acute inflammation.     
  
Discussion 
 
Here we found that IgE was rapidly induced by cutaneous exposure to the carcinogen DMBA 
and accumulated in the skin and tumors on FcRI-expressing basophils. The IgE response 
required TCR+ IELs, was autoreactive and protective against epithelial carcinogenesis. 
FcRI-expressing cells also accumulated in human skin SCCs and expression level correlated 
with disease severity. Together, our data indicate that IgE contributes to early tissue immune-
surveillance against environmental xenobiotics or toxins and has a protective role against 
epithelial tumor development.  
 
Polyaromatic hydrocarbons such as DMBA are ubiquitous and arise from many sources, 
including car emissions and tobacco smoke14, 15. They are the main organic constituent in air 
pollution, and their levels correlate with the prevalence and severity of atopic dermatitis23, 24. 
In mice, chronic skin exposure to air pollutants can induce atopic dermatitis-like features and 
IgE production. However, whilst the skin gene expression depends on ligation of the aromatic 
hydrocarbon receptor (AhR) by polyaromatic hydrocarbons, the increase in IgE does not25. 
Consistent with this, we found that initiation of IgE after topical DMBA depended on epithelial 
DNA-damage and not direct AhR engagement. Host DNA can selectively induce IgE26, 
suggesting that dying cells have unique IgE adjuvant activity. Furthermore, expression of 
autologous stress-antigens, such as NKG2D-ligands, on damaged skin epithelia promotes IgE 
production12. Topical TPA also induces NKG2D-ligand expression27, which may partly 
explain the induction of IgE by this agent. However, sequencing analysis revealed that different 
types of tissue-damage initiate distinct IgE repertoires. In humans, self-reactive IgE have been 
found in patients with systemic lupus erythematous28, 29, bullous pemphigoid30, atopic 
dermatitis31 and primary immune deficiencies32. These data suggests that IgE responses are 
potently promoted by autologous cell stress and/or damage, which is induced by skin exposure 
to environmental xenobiotics.  
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IELs provide a ‘first line of defense’ in epithelial tissues. A large proportion of IELs carry 
TCRs and are autoreactive in nature as they express receptors for tissue-specific stress-
molecules33. We show that following DMBA-induced epithelial damage IELs elicited rapid 
IgE in the parafollicular regions and subsequently triggered a conventional adaptive response 
requiring polyclonal TCR+ CD4+ T cells producing IL-4. This mode of IgE induction differs 
from regulation of self-reactive ‘natural IgE’, which is also  T cell-driven, but is independent 
of  T cells and MHCII34, 35. Deep-sequencing of IgG1+ and IgE+ GC B cells and PCs 
demonstrated that  T cells shaped the repertoire and the nature of the antibodies produced. 
Thus, antibody deep-sequencing revealed a previously unrecognized mode of B cell selection 
dictated by tissue-resident IELs. 
 
 T cells and tissue-specific IELs are key players in host defense against cancer, which is 
considered to reflect innate properties such as cytotoxicity and cytokine production11, 13, 27. 
Here we show that they can provide a ‘second line of host defense’ via initiation of adaptive 
autoreactive IgE responses and FcRI-expressing effector cells. Our findings that endogenous 
IgE can suppress tumor growth are supported by evidence that immunization with tumor 
antigen-specific IgE can eradicate tumors and is more effective than IgG136, 37. How IgE 
inhibits tumor growth in our model remains to be determined, however it required FcRI 
expression and mast cells were not essential, suggesting it may involve soluble factors and/or 
cytotoxicity mediated by basophils. 
 
In humans, epithelial skin cancers are on the rise38, 39. In addition to UV-irradiation, 
environmental chemical carcinogens can also lead to skin SCC development, as indicated by 
the causal link between scrotal SCC and soot exposure, which contains polyaromatic 
hydrocarbons, in chimney sweeps40. Moreover, tobacco smokers, who are exposed to high 
amounts of polyaromatic benz[a]antracene, have a 50% increased likelihood of developing skin 
SCC41. Studies on IgE and cancer risk in humans show a significant, albeit weak, negative 
correlation between serum IgE and overall cancer risk42, 43. In addition, FceR1a was reported 
among the top 50 genes associated with positive survival in 39 human malignancies44. The 
presence of intratumoral  T cells was the most favorable prognostic indicator of cancer 
survival44, while a high number of infiltrating PCs was also strongly associated with good 
clinical outcome44. Consistent with these observations, we found that FcRI-expressing cells 
were abundant in human SCCs and there was an inverse correlation between expression of 
FceR1a and more advanced disease. Of note, the use of omalizumab, a mAb blocking IgE, has 
been associated with more frequent development of cancer, particularly epithelial and solid 
organ cancers45.  
Together these findings suggest that the IgE-FcRI axis is part of a tumor-protective immune 
response and provides support for the ‘toxin hypothesis’, which proposes that IgE is a host 
defense mechanism against non-infectious cell-damaging environmental xenobiotics. 
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Methods 
 
Mice  
Genetically altered mice were generated as previously described. Tcrd-/-46, Tcrb-/-47, Il4-/-48, 
Langerin-DTA49 (LC-deficient) and Vg5Vd1-/-50,51 were on the FVB/N background after > 10 
backcrosses; Igh-7-/-52, FceR1a-/-53 and Cpa3Cre/+54 were on the BALB/c background after >10 
backcrosses; and OTII Tg55, Tcrb-/-56, CD19-Cre57 and Bcl6fl/fl58 were on the C57BL/6 
background. Strain-matched wild-type control animals were purchased from Charles River. 
Mice were bred and maintained in individually ventilated cages under specific pathogen-free 
conditions. Age-matched, female mice were used for all experiments at ≥ 7 weeks of age and 
selected at random from a large pool when allocated to experiments. All studies were approved 
by Imperial College AWERB (Animal Welfare and Ethical Review Body) and by the UK 
Home Office. Experiments involving cancer studies strictly adhered to the guidelines set out 
by the National Cancer Research Institute (NCRI) and Workman et al. in ‘Guidelines for the 
Welfare and Use of Animals in Cancer Research’59. All studies using animals were conducted 
following the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines60.  
 
Chemical cutaneous damage and carcinogenesis  
Chemicals 7,12-Dimethylbenz[a]anthracene (DMBA) and 12-0-tetradecanoylphorbol-13-
acetate (TPA) were purchased from Sigma and dissolved in acetone and 100% ethanol 
respectively. Acute damage was induced by exposing the dorsal sides of the ear skin to a single 
or repeated 200nM dose of DMBA or 2.5nM dose of TPA, in 25l. 
For cutaneous carcinogenesis age-matched female mice were used at 7 weeks of age. The 
dorsal back area was shaved with a surgical blade and mice rested for 1 week. Applications of 
chemicals and tumor monitoring were performed as previously described13. In brief, 200nM 
DMBA was carefully and slowly applied by pipette, in a l volume, to the entire shaved 
skin area. Mice were rested for one week and 100nM DMBA then applied weekly. Hair 
regrowth during the experiment was gently removed by clipping with trimmers. Mice were 
monitored daily and cutaneous tumors were counted and measured with a caliper once weekly. 
Back skin and tumors were evaluated by visual inspection by an observer blinded to the 
experimental groups.  
 
UV-irradiation 
The back skin of FVB mice was shaved using electrical clippers 3 days before UV-irradiation. 
Mice were exposed to the UV light source in their cages placed under four 100 W UV lamps 
with the spectral output 270-350 nm (predominantly UVB) (Philips TL12 lamps). The total 
dose of UVB radiation was monitored during each exposure using an IL-400 A UVB 
photometer (International Light). Mice were given 100mJ/cm2 three times a week.  
 
Tissue Processing 
Tissue was cut into small 1mm2 pieces using a scalpel blade and incubated for 2 hrs in digestion 
buffer containing 25ug/ml Liberase (Roche), 250ug/ml DNAseI (Roche) and 1x DNAse buffer 
(1.21 Tris base, 0.5g MgCl2 and 0.073g CaCl2) at 37°. Following digestion, tissue was 
transferred into C-tubes (Miltenyi Biotech) containing RPMI-1640 media (Thermo Fisher) 
supplemented with 10% heat-inactivated foetal calf serum, 1% Penicillin-Streptomycin-
Glutamine (Thermo Fisher) and physically disrupted using a Miltenyi cell dissociator. Cell 
suspensions were then filtered and cells counted using a CASY cell counter (Roche).  
 
Flow cytometry 
Cell suspensions were blocked for non-specific binding using antibody against FcR (2.4G2) 
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and 2% normal rat serum (Sigma) prior to any staining protocols. For staining of cell surface 
markers, cell suspensions were stained with fluorochrome-conjugated antibodies or 
appropriate isotype control with the addition of a fixable, live/dead discrimination dye 
(Invitrogen) for 25 min and subsequently washed. Intracellular staining was then carried out 
using an Intracellular Staining kit as per manufacturer’s instruction (ThermoFisher Scientific). 
Cells were fixed for 10 min at 4°C, washed with Perm buffer and stained for intracellular 
markers for 25 min. For intranuclear γH2AX staining, cells were fixed/permeablized in ice-
cold 70% ethanol at -20°C for 2 hrs, blocked with 2% normal mouse serum (Sigma), Fc-block 
and 2% fetal calf serum for 15 min, followed by 45 min staining for γH2AX at room 
temperature. Stained cells were analyzed using BD FACSVerse and Fortessa X20 (BD 
Biosciences, NJ, USA) machines. Data analysis was performed using FlowJo 10 for Mac 
(TreeStar, OR, USA).  
Antibodies were sourced from eBioscience unless otherwise stated. The following antibodies 
were used: anti-CD45 (30-F11), anti-B220 (RA3-6B2), anti-CD38 (90/CD38, BD), anti-
CD138 (281-2, BD), anti-CD95 (Jo2), anti-GL7 (GL-7), anti-CD3 (145-2C11, Biolegend), 
anti-IgE (23G3), anti-IgG1 (M1-14D12), anti-IgG2a (R19-15, BD), anti-TCRβ (H57-597), 
anti-TCRγδ (eBioGL3), anti-Vγ5 (536), anti-Vγ4 (UC3-10Ab, Biolegend), anti-CD117 (2B8), 
anti-CD41 (MWReg30, Biolegend), anti-FcRI (MAR-1, Biolegend), anti-IL-4 (11B11), anti-
IL-6 (MP5-20F3, Biolegend), anti-CD63 (NVG-2, Biolegend) and H2AX (JBW301, 
Millipore).  
 
ELISA 
For IgG1 and IgG2a antibodies, NUNC Immune Maxisorp 96-well plates (Thermo Scientific) 
were coated with 5 μg/ml goat anti-mouse IgH+L (Southern Biotech) in borate buffered saline 
at 37°C for 3hr. After washing, plates were blocked with PBS containing 0.5% BSA for 1 hr 
at room temperature, and appropriately diluted sera added and incubated overnight at 4°C. 
After washing, plates were incubated with alkaline phosphatase-conjugated polyclonal goat 
anti-mouse IgG1 or IgG2a (also detects IgG2c in C57BL/6 mice) (both Southern Biotech) for 
5 hr at 4°C. Following further washing, the alkaline phosphatase substrate pNPP (Sigma) was 
added and absorbance measured at 405 nm. Total IgE was measured by an IgE capture method. 
Sera to be tested and IgE standard were added to plate wells coated with 1 μg/ml rat monoclonal 
anti-mouse IgE (PharMingen) and blocked with 1% rat serum. Biotinylated rat monoclonal 
anti-mouse IgE (PharMingen) at 1 μg/ml were then added and incubated for 2h at 37°C. After 
washing in PBS 0.05% Tween, plates were incubated with alkaline phosphatase-
conjugated Streptavidin (PharMingen) for 1 hr at 37°C. After washing, detection of antibody 
levels was carried out by addition of alkaline phosphatase substrate pNPP (Sigma) and 
absorbance measured at 405 nm.  
For IgE ds-DNA autoreactivity, MaxiSorp plates were coated with 1 μg/ml rat monoclonal 
anti-mouse IgE (PharMingen) and blocked with 1% rat serum and 3% milk. Serum samples 
were screened at 1:25 dilution. 100 ng/ml biotinylated herring sperm ds-DNA (Promega) was 
then added and incubated overnight at 4°C. After washing in PBS 0.05% Tween, plates were 
incubated with alkaline phosphatase-conjugated Streptavidin (PharMingen) for 1 hr at 37°C. 
After washing, detection was carried out by addition of alkaline phosphatase substrate pNPP 
(Sigma) and absorbance measured at 405 nm. Autoantibody levels were expressed in arbitrary 
ELISA units. 
 
HEp-2 staining 
Auto-reactivity of IgE was tested by indirect immunofluorescence using HEp-2 cells. Serum 
samples were diluted appropriately (tested in dilutions between neat – 1:25, depending on IgE 
titers) and incubated on HEp-2 slides (Bio-Rad) overnight at 4°C. After washing in PBS, slides 
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were incubated with purified rat anti-mouse IgE (BD) for 2hrs, washed again and further 
incubated with anti-rat 555 secondary antibody (ThermoFisher) for 1hr at room temperature. 
As controls, serum from similarly treated IgE-deficient mice was also assessed as well as naïve 
wild-type serum. Slides were thoroughly washed and mounted with Vectashield containing 
DAPI (Vectashield) and visualised with a Leica DM4 fluorescence microscope (Leica). 
 
Immunofluorescent staining of tumor samples 
Tumors were removed from the back along with a small piece of adjacent skin and snap frozen 
in OCT on dry ice. 6 m sections were cut using a Leica JUNG CM1800 cryostat and stored 
at -80ºC. For staining, slides were returned to room temperature before fixation with 4% 
paraformaldhyde for 15min. Samples were then blocked in 5% goat serum for 1 hr at room 
temperature before staining with rat anti-mouse IgE (BD) overnight at 4°C. Following staining, 
samples were washed and incubated with alexa-fluor 555 conjugated, goat anti-rat IgE 
(ThermoFisher). After extensive washing, samples were mounted in VectaShield containing 
DAPI (Vectashield) and visualised with a Leica SP5 confocal laser-scanning microscope 
(Leica).  
 
Epidermal sheets  
Ears were collected, split into dorsal and ventral sides and floated dermis side-down in 0.5 M 
NH4SCN for 40 minutes, 37°C, 5% v/v CO2. Subsequently, intact epidermal sheets were 
isolated and washed in PBS. They were then fixed in ice-cold acetone at -20C for 15 minutes, 
followed by rehydration in PBS. Non-specific binding to the epidermal tissue was blocked with 
2% BSA for 1 hr and then 1:25 dilution of test sera was added and incubated overnight at 4°C. 
Any IgE binding to the tissue was visualized by first incubating with rat anti-mouse IgE (BD) 
followed by alexa-fluor 555 conjugated, goat anti-rat IgE both for 1 hr at room temperature. 
After extensive washing in PBS, samples were mounted in VectaShield containing DAPI 
(Vectashield) and visualised with a Leica SP5 confocal laser-scanning microscope (Leica).  
 
Adoptive Transfer experiments 
Whole CD4+ T cells were isolated from the spleens of donor wild-type and Il4-/- mice (using 
Miltenyi MACS isolation kits). For OTII transfer experiments, OTII Tg CD4+ T cells were cell 
sorted using OVA-peptide loaded tetramers (NIH, tetramer facility). 2x106 cells were 
intravenously injected, mice were rested for 24 hr and the dorsal ear skin then exposed to 
DMBA as described above.  
 
BM chimeras  
Wild-type, Tcrd-/- and Il4-/- mice were sub-lethally irradiated (750 rad) and immediately 
reconstituted with 5x106 donor BM cells by intravenous injection. Mice were left for 8 weeks 
to fully reconstitute the haematopoietic cells, and then exposed to DMBA on the skin as 
described. Chimerism was assessed by FACS analysis of peripheral lymph nodes and skin 
tissue at the end of the experiments. 
 
qRT-PCR and primer sequences  
RNA was extracted from ammonium-fixed epidermis, or tumor tissue, preserved in RNA-later, 
using an RNEasy Mini kit (Qiagen). RNA was dissolved in nuclease-free water, and yield and 
purity were determined. Complementary DNA (cDNA) was synthesised from RNA with an 
iScript cDNA synthesis kit (Bio-Rad) as per the manufacturer’s instructions. cDNA was diluted 
in nuclease-free double-deionized water for qRT–PCR. All primers were single-stranded DNA 
oligonucleotides (Sigma) that were intron-spanning as verified by NCBI Primer-Blast tool. 
Real-time PCR product was detected with SYBR Green (Life) measured continuously with a 
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ViiA 7 Real-Time PCR system (Applied Biosystems, CA, USA). Ct values for genes of interest 
were normalized against Ct values of the housekeeping gene Cyclophilin (Cyc) using the 2-ΔCt 
method. The following primers were used: IgE:  F (5’-
CAAGTCAGCCAAGAACTTCAC-3’), R (5’-GACAGGTCGAACTAGGATAGTC-3’), 
IgG1: F (5’-TTGCATATGTACAGTCCCAG-3’), R (5’-GTCAGAGTAATGGTGAGCAC-
3’), IgM: F (5’-AAGACTGGAATAACAGGAAGGA-3’), R (5’-
GTTTGTGCACCTCATTGGG-3’), Rae1: F (5’-TGGACACTCACAAGACCAATG-3’), R 
(5’-CCCAGGTGGCACTAGGAGT-3’), IL-4: F (5’-CATCGGCATTTTGAACGAG-3’), R 
(5’-CGAGCTCACTCTCTGTGGTG-3’), IL-6: F (5’-TGATGGATGCTACCAAACTGG-3’), 
R (5’-TTCATGTACTCCAGGTAGCTATGG-3’), IL-33: F (5’-
CACATTGAGCATCCAAGGAA-3’), R (5’-AACAGATTGGTCATTGTATGTACTCAG-
3’), Cyc: F (5’-CAAATGCTGGACCAAACACAA-3’), R (5’-
CCATCCAGCCATTCAGTCTTG-3’).  
 
Immunoglobulin sequencing and analysis 
Mice were treated twice with DMBA or TPA to the dorsal side of the ear skin, 3 days apart. 
One week after the last exposure, draining-LNs were collected and germinal center B cells 
(B220+CD95+GL7+) and plasma cells (FSChiCD95hiCD138+) cell sorted on a BD FACS Aria 
III (BD Biosciences, NJ, USA). RNA was extracted using RNEasy Micro kits (Qiagen) and 
reverse transcriped using SuperScript™ III Reverse Transcriptase (ThermoFisher). Sequences 
were amplified using Phusion High-Fidelity DNA Polymerase (NewEngland Biolabs) to 
ensure accuracy and robust performance for large PCR products. PCR with a primer in the 
constant Cregion5’-CTAGGGTCATGGAAGCAGTGCC-3’ or C1 region 5’-
GGGAAATAGCCCTTGACCAGG-3’ in combination with a promiscuous V region primer 
(binding all Vh genes) 5’-GAGGTGCAGCTGCAGGAGTCTGG-3’ was performed. All 
primers were labeled at either end with Multiplex Identifiers (MIDs) for multiplexing. PCR 
thermal cycling was as follows: 98C, 30 sec; 30x (98C, 30 sec; 60C, 30 sec; 72C, 35 sec); 
and 72C, 10min. Amplicons were purified by gel extraction using QIAquick PCR purification 
kit (Qiagen) and deep-sequenced by long-read 454 pyrosequencing on the Genome Sequencer 
FLX system (Roche). Raw sequencing data was presented in. FASTA format and unproductive 
sequences removed (data cleanup stages as described61).  
Analysis was performed as previously described61. In short: sequences were assigned to 
individual samples according to their MID. V(D)J gene assignment of individual sequences 
were annotated using IMGT/HighV-Quest and the mouse database. Mean values of V(D)J gene 
usage were calculated before 3D bubble plots were created using the R package plot3D. 
Repertoire diversity was characterized using the Hill diversity index62, 63 and plotted using the 
Alakazam package17. Physiochemical properties of the CDRH3 region were calculated using 
the R package Peptides. Physiochemical properties included length, isoelectric point (pI), 
frequencies of amino acid classes in the CDRH3 region, and Kidera factors. Kidera factors are 
a set of 10 independent factors encapsulating information from ~180 different measurable 
biophysical characteristics of the 20 amino acids18. Principal component analysis of Kidera 
factors was performed using the prcomp function in R using Minkowski distances as previously 
described64.  
 
Human tissue 
For FACS analysis, freshly excised SCC tissue and peripheral blood were obtained from 12 
patients during surgery at the Dermatology Department, University Hospital Southampton 
NHS Foundation Trust. Ethics were provided by the South Central Hampshire B NRES 
Committee (reference number 07/H0504/187). All participants recruited to the study provided 
informed consent for blood and tissue samples to be used for research purposes. All tumor 
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tissue used in the study was confirmed SSCs with a diameter > 8mm. Non-lesional skin was 
histopathologically normal and > 6mm away from the tumor edge. To obtain single cell 
suspension, tumor samples were cut into small pieces and enzymatically digested with 1 mg/ml 
collagenase I-A (Sigma) and 10 µg/ml DNAse I (Sigma) in RPMI medium at 37°C for 1.5 
hours. The resulting suspension was passed through 70µm cell strainers and centrifuged in 
Optiprep (Axis-Shield). PBMCs were isolated from venous blood from the SCC patients by 
centrifugation with Lymphoprep (Axis-Shield). Single cell suspensions were stained for FACS 
against CD45 (2D1) and FcR1 (MHE-18) (both BioLegend). Cells were gated on FSC and 
SSC and dead cells excluded using near IR live/dead stain (Invitrogen).  
For immunohistochemistry on human SSC tissue; 5µm tissue sections were cut from formalin-
fixed paraffin-embedded samples and placed onto 3-aminopropyltriethoxysilane (APES)-
coated microscope slides. Sections were deparaffinised in xylene and rehydrated through 
graded alcohols. Endogenous peroxidase was inhibited with 0.5% hydrogen peroxide, prior to 
antigen retrieval by microwaving in 10 mM citrate buffer, pH 6. Endogenous avidin and biotin 
were blocked (Vector Labs), before Dulbecco’s Modified Eagle’s Medium (Gibco) containing 
1% bovine serum albumin (Sigma) and 20% foetal bovine serum (Gibco) blocking medium 
was applied. Primary antibody (FcER1 (9E1), 1:20 dilution (Abcam)) was then left on the 
sections for 16 hours at 4°C before 3 Tris buffered saline (TBS) washes, followed by 
application of biotinylated goat anti-mouse (1:400 dilution, Jackson ImmunoResearch) for 30 
minutes. After 3 TBS washes, streptavidin-biotin complexes (Vector Labs) were applied, 
before being washed with TBS x 3 and application of diaminobenzidine (DAKO). After 
washing with TBS, sections were counterstained with Mayer’s Haematoxylin (Sigma) and 
dehydrated through graded alcohols and xylene. Sections were mounted in DPX mountant 
(Sigma) and coverslips applied. Slides were imaged at 2x and 20x magnification using an 
Olympus Dotslide microscope and analysed using OlyVIA software. 
For SSC tumor gene expression, fixed frozen paraffin embedded skin samples from 56 patients 
obtained from the University of Dundee, Tayside NHS Trust and Greater Glasgow and Clyde 
NHS Trust were analyzed. The study was conducted according to the Declaration of Helsinki 
Principles and all patients donating samples to this study provided written, informed consent 
in accordance with ethical approval from the East of Scotland Research Ethics Service 
(EoSRES) REC 1. SSC tumors were graded by an experienced dermatopathologist as low risk 
or high risk based on the Scottish Intercollegiate Guidelines Network for cutaneous SCC. In 
addition, peri-lesional skin (histopathologically normal looking skin > 4 mm away from the 
tumor edge) and abdominal non-UV exposed skin were also analyzed. Total RNA was 
extracted using Qiagen RNeasy extraction kit and directly hybridized using the NanoString 
PanCancer and PanCancer Immune expression panel and analyzed on a nCounter 
(NanoString).  
 
Statistical evaluation 
The statistical significance of difference between experimental groups was determined using 
two-tailed Student’s t-test for unpaired data, Wilcoxon test for paired samples, one-way 
ANOVA or linear regression, where appropriate, with results deemed significant at p<0.05. 
Stars of significance correlate to: *p<0.05; **P<0.01; ***P<0.001 and ****p<0.0001. 
Statistics was performed with GraphPad Prism 6.00 for Mac (GraphPad; La Jolla, CA, USA).  
 
Data availability 
The data supporting the findings of this study are available from the corresponding author 
upon request. RNA sequencing data is available from the public repository on the National 
Center for Biotechnology Information’s Sequence Read Archive in raw format (BioProject: 
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PRJNA417372; BioSample accession: SAMN07985450, SAMN07985451, SAMN07985452, 
SAMN07985453, SAMN07985454, SAMN07985455). 
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Figure legends 
 
Figure 1. Carcinogen-induced epithelial cell damage triggers a rapid local and systemic 
IgE response 
(a-c) ELISA of IgE in serum of (a) wild-type FVB mice treated with a single topical dose of 
200nmol DMBA or vehicle control (acetone) on shaved back skin (n=10), (b) Langerin-DTA 
mice (n=5) and their non-transgenic littermate controls (NLC) (n=4) exposed to DMBA as in 
(a), (c) wild-type FVB mice exposed topically to 200nmol DMBA once weekly (n=9/group). 
Sera were analyzed for IgE at indicated time points and data expressed as mean ± SEM. (d) 
FACS analysis of IgE-bearing cells in naïve skin, DMBA-treated skin 7 days after exposure 
and in DMBA-induced skin tumors. Mast cells were defined as CD45hicKit+IgE+ and basophils 
as CD45locKit-IgE+. Representative flow plots and enumeration shown (n=5 naïve skin, n=7 
DMBA skin, n=6 tumors). (e) Representative image of IgE staining (red) in a DMBA-induced 
tumor. Nuclei in blue. Scale = 1mm. Image is representative of tile-scans from 6 independent 
tumors. (f) Quantitative RT-PCR analysis of mature immunoglobulin transcripts in tumors or 
tumor adjacent skin following DMBA carcinogenesis. Data are expressed as mean ± SEM 
relative to the control gene cyclophylin (n=7/group). Statistics using two-tailed unpaired 
Student’s t-test (a and f), multiple t-tests (b) or one-way ANOVA testing for linear trend of IgE 
increase with time (c); **p<0.01, ***p<0.001 and ****p<0.0001. Data are representative of 3 
(a,c,f), 2 (b) or 4 (d) independent experiments with similar results.  
  
Figure 2. Topical carcinogen exposure induces local B cell class-switching resulting in a 
dominant IgE response 
(a-c) FACS analysis of humoral immunity in the skin draining LNs of (a-b) wild-type FVB 
mice exposed topically to DMBA on the dorsal side of the ears twice, 3 days apart, and 
analyzed 7 days after last exposure and (c) wild-type FVB mice exposed to DMBA once 
weekly on shaved back skin and analysed 7 days after last exposure. (a) Total LN cells (left 
panel) and the number of GC B cells (right panel) defined as B220+CD95+GL7+ LN cells were 
enumerated and compared to naïve wild-type mice. Representative flow plots show GC gated 
B cells and intracellular immunoglobulin staining to analyse GC B cell class-switching. (b) 
Representative flow plots and enumeration of PCs, gated as FSChiCD95+CD138+ cells, and 
intracellular immunoglobulin staining to determine isotype switching. (a-b) naïve controls 
(n=9), DMBA treated (n=11). (c) The axillary LN B cell response was analyzed weekly at 
indicated time-points (n=3 per time-point). Statistical analysis by two-tailed Student’s t-test for 
unpaired data; *p<0.05, ***p<0.001 and ****p<0.0001. ns = not significant. Data show one 
experiment representative of 5 (a,b) and 2 (c) independent experiments with similar results. 
Enumerated data are presented as mean ± SEM. 
 
Figure 3. Carcinogen-induced IgE protects against carcinogenesis 
(a-b) Tumor susceptibility expressed as tumor latency (time to appearance of first tumor), 
tumor incidence (average number of tumors per mouse) and tumor area (average tumor size 
per mouse) in (a) BALB/c wild-type and Igh7-/- mice (n=14/group) and (b) BALB/c wild-type 
(n=10) and FceR1a-/- (n=11) mice following DMBA-induced carcinogenesis. Data are 
expressed as mean ± SEM and statistical significance assessed using Log-rank (Mantel-Cox) 
test for tumor latency and linear regression for tumor incidence and area. (c) FACS analysis of 
FcRI+ cells among total CD45+ leukocyte infiltrate in human SSC tissue, peri-lesional skin 
and matched blood samples (n=12 for SSC and n=10 for peri-lesional skin and blood). Red 
triangles depict mean proportion of FcRI+ cells in the group. Statistical analysis by paired 
Wilcoxon test; **p<0.01. (d) Tissue transcripts of FceR1a in whole human skin and SSC tissue 
were analyzed by NanoString nCounter. The tissue was collected and scored independently for 
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‘tumor risk’ by an experienced dermatopathologist; non-UV (n=3), peri-lesional (n=6), low 
risk SSC (n=12), high risk SSC (n=24) and metastasis (n=11). Log2 RNA counts of FcRI are 
shown for individual ‘risk groups’ and presented as mean ± SEM. Statistics using one-way 
ANOVA and testing for linear trend of expression between ‘risk groups’. Data in (a,b) are 
representative of 2 independent experiments with similar results. WT = wild-type. 
   
Figure 4. Carcinogen-induced humoral immunity depends on T cell-derived IL-4 
(a) FACS analysis of humoral immunity in the skin draining LNs of FVB wild-type (n=6), Il4-
/- (n=5) and Tcrb-/- (n=5) mice exposed topically to DMBA on the dorsal side of the ears twice, 
3 days apart, and analysed 7 days after the last exposure relative naïve wild-type controls (n=6). 
Graphs show number of total LN cells, B220+CD95+GL7+ GC B cells and IgG1+ or IgE+ 
FSChiCD95+CD138+ PCs presented as mean ± SEM. Representative flow plots show IgG1+ 
and IgE+ PCs in wild-type, Il4-/- and Tcrb-/- mice. (b) FACS analysis of humoral immunity in 
the skin draining LNs of Tcrb-/- mice reconstituted with wild-type CD4+ T cells (n=3) or 
Il4-/- CD4+ T cells (n=4) 1 day prior to topical DMBA exposure as described in (a). Statistics 
in (a-b) by two-tailed Student’s t-test for unpaired data; *p<0.05, **p<0.01, ***p<0.001 and 
****p<0.0001. ns = not significant. (c) Tumor susceptibility expressed as tumor latency (time 
to appearance of first tumor), tumor incidence (average number of tumors per mouse) and 
tumor area (average tumor size per mouse) in FVB wild-type and Il4-/- mice (n=9/group) 
following DMBA-induced carcinogenesis. Data are expressed as mean ± SEM and statistical 
significance assessed using Log-rank (Mantel-Cox) test for tumor latency and linear regression 
for tumor incidence and area. Data in (a,b) are representative of 3 independent experiments 
with similar results. WT = wild-type. 
 
Figure 5. Induction of tumor-protective IgE requires  TCR+ IEL 
(a) FACS analysis of humoral immunity in the skin draining LNs of FVB wild-type and Tcrd-
/- mice exposed topically to DMBA on the dorsal side of the ears twice, 3 days apart, and 
analyzed 4 or 7 days after last exposure (wild-type naïve (n=10), wild-type 4 days (n=8), wild-
type 7 days (n=10), Tcrd-/- 4 days (n=5), Tcrd-/- 7 days (n=10)). Graphs show number of total 
LN cells, B220+CD95+GL7+ GC B cells and IgG1+ or IgE+ FSChiCD95+CD138+ PCs. (b) 
ELISA of IgE in serum of wild-type and Tcrd-/- mice topically exposed to DMBA on shaved 
back skin and bled before and 4 days after exposure (n=10/group). (c-d) FACS analysis and 
enumeration of (c) LN and skin  T cells and (d) humoral immunity in the skin draining LNs 
of Tcrd-/-wild-type and wild-typeTcrd-/- chimeric mice relative to chimeric control mice 
following exposure to DMBA and analysis at day 7 as in (a) (n=5/group). (e) FACS analysis 
of IgE+ PCs in the skin draining LNs of FVB wild-type (n=6) and Vg5Vd1-/- (n=8) mice exposed 
to DMBA and analysed as in (a). Statistics in (a-d) by one-way ANOVA multiple comparison 
and (e) two-tailed Student’s t-test for unpaired data; *p<0.05, **p<0.01, ***p<0.001 and 
****p<0.0001. ns = not significant. nd = not detected. All data presented as mean ± SEM. Data 
show one experiment representative of 3 (a,b) and 2 (c,d) independent experiments with similar 
results. WT = wild-type. 
 
Figure 6.  T cells promote a distinct IgE repertoire in response to carcinogen 
(a-j) High-throughput sequencing and heavy-chain repertoire analysis of IgG1 and IgE in 
sorted B220+CD95+GL7+ GC B cells and FSChiCD95hiCD138+ PCs from skin draining LNs of 
wild-type and Tcrd-/- mice 7 days after the last of two topical exposures to DMBA (n=6/group). 
(a-b) Average clone size. (c) Average clonal diversity of IgG1 and IgE PC repertoires in wild-
type and Tcrd-/- mice (‘General diversity index (qD)’ displayed as a measure of ‘clonal 
frequencies (q)’; p<0.05 for IgE from q<22). (d) Kidera factor PCA showing IgG1+ and IgE+ 
GC B cells and PCs in wild-type (left) and Tcrd-/- mice (right). (e) 3D plot of average VDJ gene 
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family usage in IgE+ PCs in wild-type (top) versus Tcrd-/- (bottom) mice. V and D genes used 
<1% in the repertoire removed for clarity. (f-g) VD repertoire of IgE+ PCs in wild-type and 
Tcrd-/- mice with (f) showing % use of V1D2 and (g) % use of other VD combinations after 
V1D2 exclusion. (h) Kidera factor PCA, (i)  CDRH3 length and indicated characteristics and 
(j) % mutations in CDRH3 compared to germline in V3Dx clones compared to other indicated 
VD families in wild-type IgE+ PCs. Statistics by two-tailed Student’s t-test for unpaired data 
(a, b, f and g) and one-way ANOVA multiple comparison (i-j); *p<0.05, **p<0.01, 
***p<0.001 and ****p<0.0001. Data in a,b,f,g,i presented as mean ± SEM. WT = wild-type. 
 
Figure 7. DMBA-induced IgE is autoantigenic and differs from TPA-induced IgE 
(a) Autoreactive binding to HEp-2 cells of IgE in serum from DMBA-treated wild-type or Tcrd-
/- mice and TPA-treated wild-type mice (serum diluted 1:25, 1:5 and 1:5 respectively to match 
IgE titers). Examples of the most common patterns are shown, IgE binding (red) and nuclei 
(blue). (b) ELISA of anti-ds-DNA autoreactivity of IgE in serum from DMBA-treated wild-
type (n=16) or Igh7-/- (n=6) mice and naïve wild-type controls (n=5). (c) FACS analysis of 
H2AX expression in CD45- skin epithelial cells, as a measure of ds-DNA breaks, at indicated 
time-points after topical DMBA or TPA (n=8/group). (d-g) High-throughput sequencing and 
heavy-chain repertoire analysis of IgE in sorted FSChiCD95hiCD138+ PCs from skin draining 
LNs of wild-type mice 7 days after topical exposures to DMBA or TPA (n=6/group). (d) 
Average clonal diversity throughout the IgE+ PC  repertoire (‘General diversity index (qD)’ 
displayed as a measure of ‘clonal frequencies (q)’; p<0.05 throughout the repertoire). (e) 
Kidera factor PCA showing CDRH3 properties, (f) 3D plot of average VDJ gene family usage 
in TPA-induced IgE and (g) use of the 5 most common V families as % of the total repertoire 
and frequency of the V3Dx clones after topical DMBA or TPA treatment. Statistics by one-
way ANOVA multiple comparison (b and c) or two-tailed Student’s t-test for unpaired data 
(g); *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. ns = not significant. Data in b,c,g 
expressed as mean ± SEM. WT = wild-type. 
 
 
